PTN vs TECH · P/E 111, $21.8M cap vs P/E 65, rev $1.22B
Palatin Technologies, Inc. Common Stock (PTN) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Palatin Technologies, Inc. Common Stock (PTN) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PTN revenue for 2025-06-30 was $0. Net income was -$17.3M. Revenue was down 100.0% from 2024-06-30 to 2025-06-30. PTN currently screens at market cap $21.8M and trailing P/E 111.4.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PTN currently screens at market cap $21.8M and trailing P/E 111.4. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PTN and TECH stock pages for the full models.
Not investment advice.